• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】52763

【品名】methyl 4-(4-fluoro-5-methyl-2-nitrophenyl)butanoate

【CA登记号】

【 分 子 式 】C12H14FNO4

【 分 子 量 】255.2459032

【元素组成】C 56.47% H 5.53% F 7.44% N 5.49% O 25.07%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(VI)

Friedel-Crafts acylation of 2-fluorotoluene (I) with succinic anhydride (II) in the presence of AlCl3 afforded 4-(4-fluoro-3-methylphenyl)-4-oxobutanoic acid (III). Ketone (III) reduction by hydrogenation over Pd/C furnished the arylbutyric acid (IV), which was esterified to (V) by means of SOCl2 in MeOH. Subsequent aromatic ring nitration of (V) yielded (VI). After basic hydrolysis of the methyl ester of (VI), the arylbutyric acid (VII) was subjected to intramolecular cyclization in hot polyphosphoric acid producing tetralone (VIII). Reduction of the keto group of (VIII) with NaBH4, followed by dehydration of the resultant alcohol (IX) under acidic conditions, gave rise to the dihydronaphthalene (X). Hydrogenation of the olefin double bond of (X) and simultaneous nitro group reduction in the presence of PtO2 produced the amino tetralin (XI). The amino group of (XI) was further protected as the acetamide (XII) employing Ac2O and Et3N. Regioselective benzylic oxidation of (XII) with KMnO4 gave tetralone (XIII). Functionalization of the alpha position of (XIII) to ketone was achieved employing n-butyl nitrite and potassium tert-butoxide. The resulting keto oxime (XIV) was then reduced with zinc in the presence of Ac2O, yielding acetamide (XV). Both amide functions of (XV) were hydrolyzed under acidic conditions to give diamine (XVI). The aliphatic amine of (XVI) was then selectively acylated with ethyl trifluoroacetate to produce the trifluoroacetamide (XVII).

1 Chilman-Blair, K.; Mealy, N.E.; Castaner, J.; Bayes, M.; Exatecan Mesilate. Drugs Fut 2004, 29, 1, 9.
2 Terasawa, H.; Ejima, A.; Ohsuki, S.; Uoto, K. (Daiichi Pharmaceutical Co., Ltd.; Yakult Honsha Co., Ltd.); Hexacyclic cpd.. EP 0495432; JP 1993059061; US 5834476; US 6407115 .
3 Terasawa, H.; Sato, K.; Mitsui, I. (Daiichi Pharmaceutical Co., Ltd.; Yakult Honsha Co., Ltd.); Antitumor agents. JP 1994087746 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 52759 2-Fluorotoluene; o-Fluorotoluene 95-52-3 C7H7F 详情 详情
(II) 11291 Dihydro-2,5-furandione; Succinic anhydride 108-30-5 C4H4O3 详情 详情
(III) 52760 4-(4-fluoro-3-methylphenyl)-4-oxobutanoic acid C11H11FO3 详情 详情
(IV) 52761 4-(4-fluoro-3-methylphenyl)butanoic acid C11H13FO2 详情 详情
(V) 52762 methyl 4-(4-fluoro-3-methylphenyl)butanoate C12H15FO2 详情 详情
(VI) 52763 methyl 4-(4-fluoro-5-methyl-2-nitrophenyl)butanoate C12H14FNO4 详情 详情
(VII) 52764 4-(4-fluoro-5-methyl-2-nitrophenyl)butanoic acid C11H12FNO4 详情 详情
(VIII) 52765 7-fluoro-8-methyl-5-nitro-3,4-dihydro-1(2H)-naphthalenone C11H10FNO3 详情 详情
(IX) 52766 7-fluoro-8-methyl-5-nitro-1,2,3,4-tetrahydro-1-naphthalenol C11H12FNO3 详情 详情
(X) 52767 6-fluoro-5-methyl-8-nitro-1,2-dihydronaphthalene C11H10FNO2 详情 详情
(XI) 52768 3-fluoro-4-methyl-5,6,7,8-tetrahydro-1-naphthalenylamine; 3-fluoro-4-methyl-5,6,7,8-tetrahydro-1-naphthalenamine C11H14FN 详情 详情
(XII) 52769 N-(3-fluoro-4-methyl-5,6,7,8-tetrahydro-1-naphthalenyl)acetamide C13H16FNO 详情 详情
(XIII) 52770 N-(3-fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydro-1-naphthalenyl)acetamide C13H14FNO2 详情 详情
(XIV) 52771 N-[3-fluoro-7-(hydroxyimino)-4-methyl-8-oxo-5,8-dihydro-1(6H)-naphthalenyl]acetamide C13H13FN2O3 详情 详情
(XV) 52772 N-[7-(acetylamino)-3-fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydro-1-naphthalenyl]acetamide C15H17FN2O3 详情 详情
(XVI) 52773 2,8-diamino-6-fluoro-5-methyl-3,4-dihydro-1(2H)-naphthalenone C11H13FN2O 详情 详情
(XVII) 52774 N-(8-amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydro-2-naphthalenyl)-2,2,2-trifluoroacetamide C13H12F4N2O2 详情 详情
Extended Information